Brandon Jonseck completed this activity on 11/20/2020 through Stanford Medical School.
Overview
Internet Enduring Material sponsored by the Stanford University School of Medicine. Presented by the Department of Medicine at the Stanford University School of Medicine.
Experts discuss the use of immunomodulator therapies for treatment of COVID-19. Discussed hospital updates, Medical Staff updates. Flu vaccination requirements for staff shared. Preparations are in place for the respiratory virus season. Rapid testing requirements. Other topics discussed include immunomodulators for treatment of COVID-19. Talked about Tocilizumab trial for the treatment of COVID-19, NIH ACTT trial and Blaze 1 trial. Also discussed the WHO Solidarity Trial. Remdesivir is the first FDA approved treatment for COVID-19. Describe the strategy for ongoing BLAZE-1 clinical trial.
Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)
Target Audience
Specialties - All Specialties
Objectives
At the conclusion of this activity, participants should be able to:
Evaluate current clinical trials taking place in order to determine the effectiveness of immunomodulators for treating COVID-19 in the near future.
Accreditation
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Stanford immunomodulators for treatment of covid19 - brandon jonseck
1. Stanford Center for Continuing Medical Education | cme.stanford.edu | Email: StanfordCME@stanford.edu
Event ID 39327
Stanford University School of Medicine certifies that
Brandon L Jonseck, MBA
has participated for 1.00 hours in the Enduring Material titled
Medicine Grand Rounds: Immunomodulators for Treatment of COVID-
19 (Recorded Webinar)
on 11/20/2020
This Activity was designated for 1.00 AMA PRA Category 1 Credit(s)™
Accreditation
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for physicians.
Daryl Oakes, MD
Associate Dean for Continuing Medical Education
